Treatment Outcome, Medication Adherence, and Associated Factors After the Introduction of Dolutegravir-Based Antiretroviral Therapy (ART) Regimen Among HIV/AIDS Patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2026-01 · 25
DOI: 10.1177/23259582261446464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), online erschienen am 24.04.2026. Verfasst von Zenebe Negash und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Oxazines, Pyridones, Piperazines, Heterocyclic Compounds, 3-Ring. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
This study assessed treatment outcomes, medication adherence, and associated factors among human immunodeficiency virus (HIV) patients receiving dolutegravir-based antiretroviral therapy (ART) at Tikur Anbessa Specialized Hospital, Ethiopia.
Methods
A hospital-based retrospective study was conducted from February to May 2024 using medical records of patients treated between 2018 and 2020. A total of 425 records were selected through random sampling. Sociodemographic, clinical, and treatment-related data were collected using a structured tool and analyzed with SPSS.
Results
Among participants, 58.8% were female, and 76.0% were aged 31 to 60 years. Overall, medication adherence was 85.7%, and viral load suppression was achieved in 99.8% of patients. All patients were screened for tuberculosis, and 60% received isoniazid preventive therapy. Adherence was significantly associated with World Health Organization clinical stage, follow-up status, advanced HIV disease, and antiretroviral dose days.
Conclusion
Dolutegravir-based ART showed excellent virologic outcomes and high adherence levels, highlighting key factors influencing treatment success.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
- Department of Pharmacy, College of Medicine and Health Sciences, Wachemo University, Hossana, Ethiopia.
- Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
ORCID-Profile: Zenebe Negash
Zitieren
APA
Negash, Z., Fekadu, Y., Tirore, M. G., Tesfaye, Z. T., & Yismaw, M. B. (2026). Treatment Outcome, Medication Adherence, and Associated Factors After the Introduction of Dolutegravir-Based Antiretroviral Therapy (ART) Regimen Among HIV/AIDS Patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Journal of the International Association of Providers of AIDS Care (JIAPAC), 25. https://doi.org/10.1177/23259582261446464
Vancouver
Negash Z, Fekadu Y, Tirore MG, Tesfaye ZT, Yismaw MB. Treatment Outcome, Medication Adherence, and Associated Factors After the Introduction of Dolutegravir-Based Antiretroviral Therapy (ART) Regimen Among HIV/AIDS Patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2026;25. doi:10.1177/23259582261446464
BibTeX
@article{Negash2026,
author = {Negash, Zenebe and Fekadu, Yonatan and Tirore, Mengistu Girma and Tesfaye, Zelalem Tilahun and Yismaw, Malede Berihun},
title = {Treatment Outcome, Medication Adherence, and Associated Factors After the Introduction of Dolutegravir-Based Antiretroviral Therapy (ART) Regimen Among HIV/AIDS Patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia},
journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
year = {2026},
volume = {25},
doi = {10.1177/23259582261446464}
}
EUVIMED